CoChat
Sign Up
Cited by 17Advancements in Transdermal Drug DeliveryAdvanced Drug Delivery SystemsIntramuscular injections and effects

The DOI matches its Crossref record, with a small difference in title or year; the references it cites are not checked yet.

Transdermal Drug Delivery Systems

Kumar, Vipin, Praveen, Nazia, Kewlani, Prerna, Arvind, Singh, Amita, Gautam, Anurag Kumar, Mahalingam Rajamanickam, Vijayakumar·2023·Studies in Mechanobiology, Tissue Engineering and Biomaterials
DOI 10.1007/978-981-99-6564-9_13
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1007/978-981-99-6564-9_13

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Magnetic-sensitive nanocarriers (magneto liposomes or polymers) respond to external magnetic fields for targeted delivery and release.

    “Additionally, magnetic-sensitive nanocarriers, like magneto liposomes or polymers, respond to external magnetic fields for targeted delivery and release [28].”

    From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [28]

Citations

The citation lists haven’t been fetched yet

References 68 · Cited by 17

Research works printed but not linked: 82

  1. Akhtar N et al (2020) Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed Tech (Berl) 65(3):243–272 · DOI
  2. Al Hanbali OA et al (2019) Transdermal patches: design and current approaches to painless drug delivery. Acta Pharm 69(2):197–215 · DOI
  3. Ali S, Shabbir M, Nabeel Shahid M (2015) The structure of skin and transdermal drug delivery system—a review. Res J Pharm Technol 8:103 · DOI
  4. Al-Khamis KI, Davis SS, Hadgraft J (1986) Microviscosity and drug release from topical gel formulations. Pharm Res 3(4):214–217. https://doi.org/10.1023/A:1016386613239 · DOI
  5. Alkilani AZ, Nasereddin J (2022) Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. 14(6) · DOI
  6. Andrews SN, Jeong E, Prausnitz MR (2013) Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res 30(4):1099–1109. https://doi.org/10.1007/s11095-012-0946-7 · DOI
  7. Arijit D, Sibaji G, Biplab KD, Sudip D (2010) A novel technique for treating the type ll diabetes by transdermal patches prepared by using multiple polymer complexes. Int J Pharma Res Dev 9:195–204
  8. Barry BW (1988) Action of skin penetration enhancers? The lipid protein partitioning theory. Int J Cosmet Sci 10(6):281–293. https://doi.org/10.1111/j.1467-2494.1988.tb00028.x · DOI
  9. Benson HAE et al (2019) Topical and transdermal drug delivery: from simple potions to smart technologies. Curr Drug Deliv 16(5):444–460 · DOI
  10. Berlin CM (1997) Clinical report—alternative routes of drug administration—advantages & disadvantages (subject review). Pediatrics
  11. Bouwstra JA, Gooris GS (2010) The lipid organisation in human stratum corneum and model systems. Open Dermatol J 4(1):10–13. https://doi.org/10.2174/1874372201004010010 · DOI
  12. Chantasart D, Li SK (2012) Structure enhancement relationship of chemical penetration enhancers in drug transport across the stratum corneum. Pharmaceutics 4(1):71–92. https://doi.org/10.3390/pharmaceutics4010071 · DOI
  13. Chen X et al (2020) Electroporation-enhanced transdermal drug delivery: effects of logP, pK(a), solubility and penetration time. Eur J Pharm Sci 151:105410 · DOI
  14. Chien YW, Banga AK (1989) Iontophoretic (transdermal) delivery of drugs: overview of historical development. J Pharm Sci 78(5):353–354 · DOI
  15. Choudhary N, Singh AP (2021) Transdermal drug delivery system: a review. Indian J Pharm Pharmacol 8(1):5–9 · DOI
  16. Dardano P et al (2015) A photolithographic approach to polymeric microneedles array fabrication. Materials (Basel) 8(12):8661–8673 · DOI
  17. Das A, Ahmed A (2017) Natural permeation enhancer for transdermal drug delivery system and permeation evaluation: a review. Asian J Pharm Clin Res 10:5 · DOI
  18. Dermol-Černe J, Pirc E, Miklavčič D (2020) Mechanistic view of skin electroporation—models and dosimetry for successful applications: an expert review. Expert Opin Drug Deliv 17(5):689–704 · DOI
  19. Dhal S, Pal K, Giri S (2020) Transdermal delivery of gold nanoparticles by a soybean oil-based oleogel under iontophoresis. ACS Appl Bio Mater 3(10):7029–7039 · DOI
  20. Du H et al (2019) Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis. ACS Appl Mater Interfaces 11(46):43588–43598 · DOI
  21. Frei A et al (2003) A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain. J Pain Palliat Care Pharmacother 17(2):5–26 · DOI
  22. Gandhi K et al (2012) Transdermal drug delivery: a review
  23. Giacomoni PU, Dong K, Collins D, Pernodet N, Yarosh D (2011) Use of reconstructed skin specimens to analyze stratum corneum remodeling and epidermal modifications. In: Skin biopsy—perspectives. InTech https://doi.org/10.5772/23023 · DOI
  24. Green PG (1996) Iontophoretic delivery of peptide drugs. J Control Release 41(1–2):33–48. https://doi.org/10.1016/0168-3659(96)01354-5 · DOI
  25. Hadgraft J, Lane ME (2009) Transepidermal water loss and skin site: a hypothesis. Int J Pharm 373(1–2):1–3. https://doi.org/10.1016/j.ijpharm.2009.02.007 · DOI
  26. Honeywell-Nguyen PL, Bouwstra JA (2005) Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol 2(1):67–74 · DOI
  27. Igarashi T, Nishino K, Nayar SK (2007) The appearance of human skin: a survey. Found Trends® Comput Graph Vis 3(1):1–95. https://doi.org/10.1561/0600000013 · DOI
  28. Ita K (2015a) Transdermal delivery of drugs with microneedles-potential and challenges. Pharmaceutics 7(3):90–105 · DOI
  29. Ita KB (2015b) Chemical penetration enhancers for transdermal drug delivery—success and challenges. Curr Drug Deliv 12(6):645–651 · DOI
  30. Jayaprakash R, Hameed J, Anupriya A (2017) An overview of transdermal delivery system. Asian J Pharm Clin Res 10(10):36. https://doi.org/10.22159/ajpcr.2017.v10i10.19909 · DOI
  31. Jayaswal SB, Sood R (1987) Transdermal drug delivery system—a review. Eastern Pharm 30(357):47–50
  32. Jeong WY et al (2019) Transdermal delivery of Minoxidil using HA-PLGA nanoparticles for the treatment in alopecia. Biomater Res 23:16 · DOI
  33. Jeong WY et al (2021) Recent advances in transdermal drug delivery systems: a review. Biomater Res 25(1):24 · DOI
  34. Karande P, Mitragotri S (2009) Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochimica et Biophysica Acta (BBA) Biomembranes 1788(11):2362–2373. https://doi.org/10.1016/j.bbamem.2009.08.015 · DOI
  35. Kavadya Y, Behera B, Mohanty P, Routray D, Ghosh S, Das L (2018) Study of physiological and pathological skin changes in neonates: an east Indian perspective. Indian J Paediatr Dermatol 19(1):40. https://doi.org/10.4103/ijpd.ijpd_21_17 · DOI
  36. Keleb E, Sharma RK, Mosa EB, Aljahvi AZ (2010) Transdermal drug delivery system-design and evaluation. Int J Adv Pharm Sci 1:201–211
  37. Kim HM et al (2012) Transdermal drug delivery using disk microneedle rollers in a hairless rat model. Int J Dermatol 51(7):859–863 · DOI
  38. Kornick CA et al (2003) Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain. Drug Saf 26(13):951–973 · DOI
  39. Kumar R, Philip A (2007) Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Trop J Pharm Res 6(1):633–644. https://doi.org/10.4314/tjpr.v6i1.14641. ISSN: 1596-5996 · DOI
  40. Kumar SR, Jain A, Nayak S (2012) Development and evaluation of transdermal patches of colchicine. Pharm Lett 4(1):330–343
  41. Kusum Devi V, Saisivam S, Maria GR, Deepti PU (2003) Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm 29(5):495–503. https://doi.org/10.1081/DDC-120018638 · DOI
  42. Lee H et al (2018) Device-assisted transdermal drug delivery. Adv Drug Deliv Rev 127:35–45 · DOI
  43. Leppert W et al (2018) Transdermal and topical drug administration in the treatment of pain. Molecules 23(3) · DOI
  44. Lin CH, Aljuffali IA, Fang JY (2014) Lasers as an approach for promoting drug delivery via skin. Expert Opin Drug Deliv 11(4):599–614 · DOI
  45. Mitragotri S, Edwards DA, Blankschtein D, Langer R (1995) A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci 84(6):697–706. https://doi.org/10.1002/jps.2600840607 · DOI
  46. Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF (2007) Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J 1(1):36–59. https://doi.org/10.2174/1874126600701010036 · DOI
  47. Neupane R et al (2021) Transdermal delivery of chemotherapeutics: strategies, requirements, and opportunities. Pharmaceutics 13(7):960. https://doi.org/10.3390/pharmaceutics13070960 · DOI
  48. Pandey D, Akhilesh D, Prabhakara P, Kamath J (2012) Transdermal drug delivery system: a novel drug delivery system. Int Res J Pharm 3(5):89–94
  49. Parivesh S, Sumeet D, Abhishek D (2010) Design, evaluation, parameters and marketed products of transdermal patches: a review. J Pharm Res 3(2):235–240
  50. Park J et al (2019) Enhanced transdermal drug delivery by sonophoresis and simultaneous application of sonophoresis and iontophoresis. AAPS PharmSciTech 20(3):96 · DOI
  51. Pastore MN et al (2015) Transdermal patches: history, development and pharmacology. Br J Pharmacol 172(9):2179–2209 · DOI
  52. Pathan I, Setty C (2009) Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8(2). https://doi.org/10.4314/tjpr.v8i2.44527 · DOI
  53. Peña-Juárez MC, Guadarrama-Escobar OR, Escobar-Chávez JJ (2022) Transdermal delivery systems for biomolecules. J Pharm Innov 17(2):319–332 · DOI
  54. Pires LR et al (2019) A perspective on microneedle-based drug delivery and diagnostics in paediatrics. J Pers Med 9(4) · DOI
  55. Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26(11):1261–1268 · DOI
  56. Rastogi V, Yadav P (2012) Transdermal drug delivery system: an overview. Asian J Pharm 6(3) · DOI
  57. Rizwan M, Aqil M, Talegoankar S, Azeem A, Sultana Y, Ali A (2009) Enhanced transdermal drug delivery techniques: an extensive review on patents. Recent Pat Drug Deliv Formul 3(2):105–124 · DOI
  58. Roohnikan M et al (2019) A snapshot of transdermal and topical drug delivery research in Canada. Pharmaceutics 11(6) · DOI
  59. Ruby PK, Pathak SM, Aggarwal D (2014) Critical attributes of transdermal drug delivery system (TDDS)—a generic product development review. Drug Dev Ind Pharm 40(11):1421–1428 · DOI
  60. Sandhyarani G, Madhuri M (2018) Development and evaluation of fast disintegrating films and tablets of Valsartan. Int J Med Sci Pharma Res 4(1):17. https://doi.org/10.22270/ijmspr.v4i1.23 · DOI
  61. Sankar V, Johnson DB, Sivan V, Ravich V, Raghuraman S, Velrajan G, Palaniappan R, Rajasekar S (2003) Design and evaluation of nifedipine transdermal patches. Indian J Pharm Sci 65(5):510
  62. Shaila L, Pandey S, Udupa N (2006) Design and evaluation of matrix type membrane controlled transdermal drug delivery system of nicotine suitable for use in smoking cessation. Indian J Pharm Sci 68(2):829–831. https://doi.org/10.4103/0250-474X.25711 · DOI
  63. Shakya AK et al (2019) Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice. J Control Release 314:38–47 · DOI
  64. Shinde AJ, Garala KC, More HN (2008) Development and characterization transdermal therapeutics system of tramadol hydrochloride. Asian J Pharm (AJP) 2(4):265–269. https://doi.org/10.4103/0973-8398.45044 · DOI
  65. Singh S, Singh J (1993) Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med Res Rev 13 · DOI
  66. Singh MC, Naik AS, Sawant SD (2010) Transdermal drug delivery systems with major emphasis on transdermal patches: a review. J Pharm Res 3(10):2537–2543
  67. Sinha VR, Kaur MP (2000) Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 26(11):1131–1140. https://doi.org/10.1081/DDC-100100984 · DOI
  68. Sonjoy M, Thimmasetty J, Ratan GN, Kilarimath BH (2011) Formulation and evaluation of carvedilol transdermal patches. Int Res J Pharm 2(1):237–248
  69. Sood A, Panchagnula R (1999) Role of dissolution studies in controlled release drug delivery systems. STP Pharma Sci 9(2):157–168
  70. Szunerits S, Boukherroub R (2018) Heat: a highly efficient skin enhancer for transdermal drug delivery. Front Bioeng Biotechnol 6:15 · DOI
  71. Ubaidulla U, Reddy MV, Ruckmani K, Ahmad FJ, Khar RK (2007) The transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech 8(1):13–20. https://doi.org/10.1208/pt0801002 · DOI
  72. Varvel JR et al (1989) Absorption characteristics of transdermally administered fentanyl. 70(6):928–934 · DOI
  73. Verma PR, Iyer SS (2000) Transdermal delivery of propranolol using mixed grades of Eudragit: design and in vitro and in vivo evaluation. Drug Dev Ind Pharm 26(4):471–476. https://doi.org/10.1081/DDC-100101257 · DOI
  74. Verma S, Ojha A (2018) Transdermal drug delivery system: a review. Int J Med Sci Pharma Res 4(1):1–9. https://doi.org/10.22270/ijmspr.v4i1.21 · DOI
  75. Vishvakarma P, Aggrawal S, Sharma R, Sharma S (2012) Transdermal drug delivery system: review. Int Res J Pharm 23(5):50–53
  76. Wang Y et al (2022) Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Drug Deliv Transl Res 12(1):15–26 · DOI
  77. Weiner E, Victor A, Johansson ED (1976) Plasma levels of d-Norgestel after oral administration. Contraception 14:563–570. Keith AD (1983) Polymer matrix consideration for transdermal devices. Drug Dev Ind Pharm 9:605–625 · DOI
  78. Wiechers J (1992) Use of chemical penetration enhancers in transdermal drug delivery–possibilities and difficulties. Acta Pharm Nord 4(2):123
  79. Wokovich A et al (2006) Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm: Off J Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 64:1–8 · DOI
  80. Yamamoto T, Katakabe K, Akiyoshi K, Kan K, Asano T (1990) Topical application of glibenclamide lowers blood glucose levels in rats. Diabetes Res Clin Pract 8:19–22. https://doi.org/10.1016/0168-8227(90)90091-7 · DOI
  81. Zhang Y et al (2019) Advances in transdermal insulin delivery. Adv Drug Deliv Rev 139:51–70 · DOI
  82. Zhao Z, Chen Y, Shi Y (2020) Microneedles: a potential strategy in transdermal delivery and application in the management of psoriasis. RSC Adv 10(24):14040–14049 · DOI

Metadata

Authors
Kumar, V., Praveen, N., Kewlani, P., Arvind, Singh, A., Gautam, A. K., & Mahalingam Rajamanickam, V.
Affiliations
Babasaheb Bhimrao Ambedkar University (IN)
ORCID
Venue
Studies in Mechanobiology, Tissue Engineering and Biomaterials
Publisher
Springer Nature Singapore
Published
2023
Pages
333-362
ISSN
  • 1868-2006 (ISSN-L)
  • 1868-2014
DOI
10.1007/978-981-99-6564-9_13
OpenAlex
W4387896721
Cited by
17
References
68
Citations by year
2026: 4 · 2025: 10 · 2024: 2
FWCI
9.16
Type
book chapter
Language
en
Open access
closed
Licence
Locations
Studies in mechanobiology, tissue engineering and biomaterials (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Emergency Medicine › Intramuscular injections and effects
Keywords
transdermal drug delivery systems, transdermal patch, skin permeation, matrix-type patch, nanocarriers, nanoemulsions, iontophoresis, sonophoresis, electroporation, thermal ablation, macromolecule delivery, transdermal vaccine delivery, medication adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review